Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04906408Recruiting
Randomised, open-label trial in ventral hernia and Abdominal wall neoplasm (3 arms), sponsored by The Ohio State University. Primary endpoints: Rate of Infection at 6 weeks, Rate of Seroma at 6 weeks and 2 more. Started Sep 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04906408.